Iran Joins Global Top 10 in Umbilical Cord Stem Cell Solution Production
WANA (Oct 29) – Specialists in Iran have achieved a major scientific breakthrough: experts at a knowledge-based company affiliated with the Royan Institute have successfully developed one of the key components required for the use of umbilical cord blood stem cells.
The Royan Institute proudly announced that its research team has succeeded in producing an umbilical cord blood stem cell separation solution (polymer serum)—a scientific and technological milestone that places Iran among the world’s top ten countries capable of producing such an advanced biomedical material.
According to Monireh Mohammad, Head of Processing at Royan Stem Cell Technology Company, this cutting-edge solution separates umbilical cord blood stem cells from other blood components with remarkable precision and efficiency, while safely managing blood volume in patients. A distinctive feature of the serum, she noted, is its ability to extend the lifespan of stem cells and enhance their differentiation potential—enabling more effective treatments for genetic and hematologic disorders such as thalassemia, cancers, and immunodeficiency diseases.
This accomplishment marks a significant step toward the localization of advanced cell therapy technologies in Iran. Domestic production of this solution not only strengthens the country’s scientific and technical capabilities but also accelerates research and the development of new therapeutic approaches within Iran.
Hamed Daemi, faculty member at the Royan Institute, core member of the research team, and CEO of Zharf Andishan Fanavar Zist Bespar—the knowledge-based company behind the innovation—explained: “The polymer serum is used to isolate stem cells found in umbilical cord blood. This high-tech product increases both the lifespan and differentiation capacity of stem cells and can be applied in the treatment of genetic diseases, cardiovascular disorders, cancers, and other conditions. Previously, the product was imported from European countries, but it is now produced domestically in Iran at one-third of the European cost. Currently, fewer than ten countries worldwide possess the capability to manufacture it.”
Iran Produces Domestic Cord Stem Cell Polymer Serum
WANA (Oct 25) – Iranian specialists at a knowledge-based company affiliated with Royan Scientific Center have successfully produced a vital component of the umbilical cord stem cell process entirely within Iran, marking a significant step in the country’s biotechnology sector. In recent years, umbilical cord blood transplants and stem cells extracted from them have […]
He added that, beyond its prominent scientific and therapeutic advantages, the polymer serum is suitable for both clinical and laboratory applications and represents a milestone in Iran’s pursuit of self-sufficiency in advanced biomedical technologies.
The successful production of this serum stands as a testament to Iran’s growing scientific and technological capacity in the field of cell therapy—paving the way for the development of next-generation treatments and improvements in patient quality of life across the country.
